Roivant Sciences Ltd (ROIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ROIV | AMGN | VRTX | REGN | BMY |
| Company | Roivant Sciences Ltd | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 11.63 | 301.75 | 406.42 | 967.88 | 43.98 |
| High | 11.63 | 302.91 | 415.67 | 967.88 | 44.26 |
| Low | 11.41 | 299.08 | 394.03 | 957.10 | 43.90 |
| Last | 11.43 | 299.07 | 409.21 | 961.44 | 43.99 |
| Change | -0.17 | -0.41 | +6.71 | +2.80 | +0.09 |
| % Change | -1.47% | -0.14% | +1.67% | +0.29% | +0.21% |
| Volume | 1,754,583 | 1,180,492 | 1,009,625 | 158,003 | 4,975,059 |
| 20-Day Average Volume | 4,218,067 | 2,758,893 | 1,071,716 | 512,048 | 14,073,292 |
| Previous Close | 11.60 | 299.48 | 402.50 | 958.64 | 43.90 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.97 | 275.26 | 398.73 | 911.91 | 46.73 |
| 20-Day Raw Stochastic | 88.00% | 63.19% | 85.93% | 96.31% | 9.52% |
| 20-Day Relative Strength | 57.46% | 62.83% | 55.79% | 60.86% | 30.26% |
| Weighted Alpha | +23.84 | +27.83 | +18.74 | +29.75 | -36.00 |
| Today's Opinion | 100% Buy | 40% Buy | 32% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 100% Buy | 24% Buy | 8% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 56% Buy | 24% Sell | 24% Buy | 56% Buy | 32% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.28% since 04/30/24 | +9.44% since 04/30/24 | +4.94% since 04/30/24 | +8.29% since 04/30/24 | +0.34% since 04/30/24 |
| Low | 10.90 on 05/01/24 | 273.38 on 05/01/24 | 392.47 on 05/01/24 | 888.52 on 05/01/24 | 43.33 on 05/02/24 |
| High | 11.64 on 05/06/24 | 322.60 on 05/03/24 | 415.67 on 05/07/24 | 967.88 on 05/07/24 | 44.62 on 05/06/24 |
| 1-Month | |||||
| %Chg | -2.26% since 04/05/24 | +11.06% since 04/05/24 | +1.36% since 04/05/24 | +2.31% since 04/05/24 | -14.09% since 04/05/24 |
| Low | 10.27 on 04/19/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 11.80 on 04/08/24 | 322.60 on 05/03/24 | 415.67 on 05/07/24 | 967.88 on 05/07/24 | 51.68 on 04/09/24 |
| 3-Month | |||||
| %Chg | +10.44% since 02/07/24 | +1.33% since 02/07/24 | -1.64% since 02/07/24 | +2.77% since 02/07/24 | -9.35% since 02/07/24 |
| Low | 9.76 on 03/19/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 12.00 on 03/04/24 | 322.60 on 05/03/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +26.24% since 11/07/23 | +10.59% since 11/07/23 | +8.98% since 11/07/23 | +16.09% since 11/07/23 | -15.68% since 11/07/23 |
| Low | 8.47 on 11/13/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.33 on 05/02/24 |
| High | 12.00 on 03/04/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 9,347,814 | 160,633,888 | 104,029,752 | 105,222,248 | 88,989,688 |
| Shares Outstanding, K | 805,846 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 61,280,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -1,009,030,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 37,140,000 | 7,447,000,000 | 2,517,700,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | 5,096,180,000 | -113,000,000 | 968,800,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | 1.30 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 02/13/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 06/26/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.71 | 29.84 | 25.79 | 41.90 |